Abstract
The objectives of this study were to evaluate long-term safety and efficacy of phentolamine mesylate, an orally active, rapid-acting alpha-adrenergic receptor antagonist, for the treatment of men suffering from erectile dysfunction (ED). It was an open-label study involving more than 2000 patients. Men received phentolamine mesylate 40 mg or 80 mg (10 tablets/month) as needed for up to 13 months and self-assessed erectile performance using two validated questionnaires. Treatment with phentolamine mesylate was associated with increases in Erectile Function Domain score of the IIEF, successful vaginal penetrations, and in overall satisfaction. Most adverse events were mild or moderate in severity and consistent with the known pharmacodynamic properties of phentolamine. In conclusion, phentolamine mesylate is safe and effective in the long-term treatment of men with mild to moderate ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NIH Consensus Development Panel on Impotence. JAMA 1993 270: 83–90
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 1994 151: 54–61
Lue TF . Erectile dysfunction New Engl J Med 2000 342: 1802–1813
Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction New Engl J Med 1998 338: 1397–1404
Becker AJ et al. Oral phentolamine as treatment for erectile dysfunction J Urol 1998 159: 1214–1216
Data on file, Zonagen, Inc.
Rosen RC et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 1997 49: 822–830
Goldstein I . A 36-week, open label non-comparative study to assess the long-term safety of sildenafil citrate (Viagra®) in patients with erectile dysfunction Int J Clin Pract 1999 102: (suppl) 8–9
Schwartz I, McCarthy D . Sildenafil in the treatment of erectile dysfunction [letter] New Engl J Med 1998 339: 699–700
Kloner RA, Zusman RM . Cardiovascular effects of sildenafil citrate and recommendations for its use Am J Cardiol 1999 84: 11N–17N
Traish A et al. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms Int J Impot Res 1998 10: 215–223
Acknowledgements
We acknowledge the study coordinators, nurses, and the following investigators who participated in the Vasomax Study Group: Donald Gleason, Jay Young, Joel Kaufman, Marc Gittelman, Dean Knoll, Mitchell Wiatrak, Glen Wells, Gilberto Brito, Christopher Steidle, Jacques Susset, David Talley, Robert Feldman, Myron Murdock, Stacy Childs; Norman Zinner, Eugene Dula, Steve Koukol, Peter Knapp, Mark Immergut, Jeffrey Snyder, George Kornitzer, Arnold Belker, James Barada, John Byrne, Richard Harris, Gilbert McMahon, David Mobley, Stanley Bloom, Donald Kidd, Kevin Tomera, Steven Lamm.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Padma-Nathan, H., Goldstein, I., Klimberg, I. et al. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction. Int J Impot Res 14, 266–270 (2002). https://doi.org/10.1038/sj.ijir.3900885
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900885
Keywords
This article is cited by
-
Voltammetric determination of phentolamine mesylate in pharmaceutical formulations at poly (4-aminobenzene sulfonic acid)-modified glassy carbon electrode
Chemical Papers (2020)
-
Einfluss medikamentöser BPS-Therapie auf die sexuelle Funktion
Der Urologe (2018)
-
The promise of inhibition of smooth muscle tone as a treatment for erectile dysfunction: where are we now?
International Journal of Impotence Research (2012)
-
Adrenergic α-blockers: an infrequent and overlooked cause of priapism
International Journal of Impotence Research (2011)
-
Twenty years of IJIR
International Journal of Impotence Research (2008)